WOONSOCKET – CVS Health Corp. on Jan. 29 filed an antitrust suit against a Japanese pharmaceutical manufacturer over an alleged plan to illegally prevent generic versions of the drug Amitiza off the market for several years. In its complaint filed in Massachusetts District Court, CVS stated that Takeda Pharmaceuticals entered into an unlawful anti-competition agreement
Already a Subscriber? Log in
To Continue Reading This Article
Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.Learn More and Become a Subscriber
- Critical RI business news and analysis updated daily.
- 1 year of print (26 issues).
- Unlimited access to all subscriber only content on our website, on any device.
- Free email alerts.
- Annual Book of Lists Print Edition.
- All special issues produced during subscription term.
Click Here to purchase a paywall bypass link for this article
PBN Branded Content
Building a Strong Data Foundation in the Age of AI
Artificial intelligence (AI) has become a key priority in the boardroom and across management —…
Learn More
